Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Mitchel L. Zoler, PhD

Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler

News

Onyx stent meets DAPT performance goal in bleeding-risk patients

Author:
Mitchel L. Zoler, PhD
Publish date: May 11, 2020

A zotarolimus-eluting coronary stent met its FDA-set performance goal in high-bleeding-risk patients on dual antiplatelet therapy for 1 month.

  • Read More

News

Silent brain infarcts found in 3% of AFib patients, tied to cognitive decline

Author:
Mitchel L. Zoler, PhD
Publish date: May 11, 2020

MR-detected brain infarcts often developed in AFib patients on oral anticoagulation and in the absence of a...

  • Read More

News

UNTOUCHED: Inappropriate shocks cut by subcutaneous ICD improvements

Author:
Mitchel L. Zoler, PhD
Publish date: May 8, 2020

Tweaking the filtering and programing of a subcutaneous ICD cut the inappropriate-shock rate in a classic ICD patient population.

  • Read More

News

Coffee drinking linked with fewer arrhythmias

Author:
Mitchel L. Zoler, PhD
Publish date: May 7, 2020

Data from nearly 300,000 U.K. residents showed a statistically significant 3% drop in cardiac arrhythmias per...

  • Read More

News

FOURIER: Evolocumab follow-up shows no cognitive adverse effects

Author:
Mitchel L. Zoler, PhD
Publish date: May 4, 2020

A cognition survey of more than 22,000 FOURIER patients showed no compromise linked to evolocumab or sharply cut LDL-C levels.

  • Read More

News

Hydroxychloroquine-triggered QTc-interval prolongations mount in COVID-19 patients

Author:
Mitchel L. Zoler, PhD
Publish date: May 4, 2020

Two single-center reports further documented the incidence of QTc-interval prolongations in COVID-19 patients...

  • Read More

News

REPLENISH: Oral estradiol/progesterone slowed bone turnover as it cut VMS

Author:
Mitchel L. Zoler, PhD
Publish date: April 29, 2020

A U.S. approved oral estradiol/progesterone formulation for treating vasomotor symptoms linked with significant...

  • Read More

News

SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit

Author:
Mitchel L. Zoler, PhD
Publish date: April 29, 2020

Merck reports topline results from ertugliflozin’s FDA-mandated cardiovascular outcomes trial.

  • Read More

News

FDA reiterates hydroxychloroquine limitations for COVID-19

Author:
Mitchel L. Zoler, PhD
Publish date: April 24, 2020

An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...

  • Read More

News

AUGUSTUS: After ACS or PCI, aspirin gives AFib patients scant benefit

Author:
Mitchel L. Zoler, PhD
Publish date: April 24, 2020

Adding aspirin to an anticoagulant and P2Y12 inhibitor showed no net benefit, even acutely, suggesting need to target aspirin to highly selected...

  • Read More

News

ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients

Author:
Mitchel L. Zoler, PhD
Publish date: April 22, 2020

A study drawing from 1,128 hypertensive, Chinese patients with COVID-19 suggested that those on an ACEI or ARB...

  • Read More

News

PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis

Author:
Mitchel L. Zoler, PhD
Publish date: April 21, 2020

Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and...

  • Read More

News

Imaging recommendations issued for COVID-19 patients

Author:
Mitchel L. Zoler, PhD
Publish date: April 16, 2020

An expert panel organized by the Fleischner Society made recommendations on using chest radiography or CT in hospitalized COVID-19 patients.

  • Read More

News

Evidence suggests possible RAS-blocker benefit in COVID-19 patients

Author:
Mitchel L. Zoler, PhD
Publish date: April 16, 2020

Animal findings and physiologic mechanisms suggest RAS system inhibitors may benefit COVID-19 patients,...

  • Read More

News

AHA updates management when CAD and T2DM coincide

Author:
Mitchel L. Zoler, PhD
Publish date: April 13, 2020

Statement encourages and guides greater involvement by cardiovascular specialists in managing patients with...

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close